Russian govt to increase public procurement of diabetes drugs

The Russian government plans to significantly increase public procurement of drugs against diabetes this year despite the existing shortage of funds, reports The Pharma Letter’s local correspondent.

So far, the government has not yet found new sources of funding for the federal project “Fight against Diabetes,” of which only 10 billion roubles (~$12 million) has so far been reserved for it annually for the period of 2023-2025.

According to Marina Shestakova, deputy director of the State Scientific Center for Endocrinology of the Russian Ministry of Health, the register of patients with diabetes in Russia has almost five million people, most of whom are in acute need of regular administration of necessary drugs.